Your browser doesn't support javascript.
loading
The MLL recombinome of acute leukemias in 2017.
Meyer, C; Burmeister, T; Gröger, D; Tsaur, G; Fechina, L; Renneville, A; Sutton, R; Venn, N C; Emerenciano, M; Pombo-de-Oliveira, M S; Barbieri Blunck, C; Almeida Lopes, B; Zuna, J; Trka, J; Ballerini, P; Lapillonne, H; De Braekeleer, M; Cazzaniga, G; Corral Abascal, L; van der Velden, V H J; Delabesse, E; Park, T S; Oh, S H; Silva, M L M; Lund-Aho, T; Juvonen, V; Moore, A S; Heidenreich, O; Vormoor, J; Zerkalenkova, E; Olshanskaya, Y; Bueno, C; Menendez, P; Teigler-Schlegel, A; Zur Stadt, U; Lentes, J; Göhring, G; Kustanovich, A; Aleinikova, O; Schäfer, B W; Kubetzko, S; Madsen, H O; Gruhn, B; Duarte, X; Gameiro, P; Lippert, E; Bidet, A; Cayuela, J M; Clappier, E; Alonso, C N.
Affiliation
  • Meyer C; Institute of Pharmaceutical Biology/Diagnostic Center of Acute Leukemia (DCAL), Goethe-University, Frankfurt/Main, Germany.
  • Burmeister T; Charité-Department of Hematology, Oncology and Tumorimmunology, Berlin, Germany.
  • Gröger D; Charité-Department of Hematology, Oncology and Tumorimmunology, Berlin, Germany.
  • Tsaur G; Regional Children Hospital 1, Research Institute of Medical Cell Technologies, Pediatric Oncology and Hematology Center, Ural Federal University, Ekaterinburg, Russia.
  • Fechina L; Regional Children Hospital 1, Research Institute of Medical Cell Technologies, Pediatric Oncology and Hematology Center, Ural Federal University, Ekaterinburg, Russia.
  • Renneville A; Laboratory of Hematology, Biology and Pathology Center, CHRU of Lille; INSERM, UMR-S 1172, Cancer Research Institute of Lille, Lille, France.
  • Sutton R; Children's Cancer Institute Australia, Uinversity of NSW Sydney, Sydney, New South Wales, Australia.
  • Venn NC; Children's Cancer Institute Australia, Uinversity of NSW Sydney, Sydney, New South Wales, Australia.
  • Emerenciano M; Pediatric Hematology-Oncology Program-Research Center, Instituto Nacional de Cancer Rio de Janeiro, Rio de Janeiro, Brazil.
  • Pombo-de-Oliveira MS; Pediatric Hematology-Oncology Program-Research Center, Instituto Nacional de Cancer Rio de Janeiro, Rio de Janeiro, Brazil.
  • Barbieri Blunck C; Pediatric Hematology-Oncology Program-Research Center, Instituto Nacional de Cancer Rio de Janeiro, Rio de Janeiro, Brazil.
  • Almeida Lopes B; Pediatric Hematology-Oncology Program-Research Center, Instituto Nacional de Cancer Rio de Janeiro, Rio de Janeiro, Brazil.
  • Zuna J; CLIP, Department of Paediatric Haematology/Oncology, Charles University Prague, 2nd Faculty of Medicine, Prague, Czech Republic.
  • Trka J; CLIP, Department of Paediatric Haematology/Oncology, Charles University Prague, 2nd Faculty of Medicine, Prague, Czech Republic.
  • Ballerini P; Biological Hematology, AP-HP A. Trousseau, Pierre et Marie Curie University, Paris, France.
  • Lapillonne H; Biological Hematology, AP-HP A. Trousseau, Pierre et Marie Curie University, Paris, France.
  • De Braekeleer M; Université de Bretagne Occidentale, Faculté de Médecine et des Sciences de la Santé, Laboratoire d'Histologie, Embryologie et Cytogénétique & INSERM-U1078, Brest, France.
  • Cazzaniga G; Centro Ricerca Tettamanti, Clinica Pediatrica Univ. Milano Bicocca, Monza, Italy.
  • Corral Abascal L; Centro Ricerca Tettamanti, Clinica Pediatrica Univ. Milano Bicocca, Monza, Italy.
  • van der Velden VHJ; Erasmus MC, Department of Immunology, Rotterdam, The Netherlands.
  • Delabesse E; CHU Purpan, Laboratoire d'Hématologie, Toulouse, France.
  • Park TS; Department of Laboratory Medicine, School of Medicine, Kyung Hee University, Seoul, Korea.
  • Oh SH; Department of Laboratory Medicine, Inje University College of Medicine, Busan, Korea.
  • Silva MLM; Cytogenetics Department, Bone Marrow Transplantation Unit, National Cancer Institute (INCA), Rio de Janeiro, Brazil.
  • Lund-Aho T; Laboratory of Clinical Genetics, Fimlab Laboratories, Tampere, Finland.
  • Juvonen V; Department of Clinical Chemistry and TYKSLAB, University of Turku and Turku University Central Hospital, Turku, Finland.
  • Moore AS; The University of Queensland Diamantina Institute, The University of Queensland, Brisbane, Queensland, Australia.
  • Heidenreich O; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
  • Vormoor J; The Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Zerkalenkova E; Dmitry Rogachev National Scientific and Practical Center of Pediatric Hematology, Oncology and Immunology, Moscow.
  • Olshanskaya Y; Dmitry Rogachev National Scientific and Practical Center of Pediatric Hematology, Oncology and Immunology, Moscow.
  • Bueno C; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.
  • Menendez P; CIBER de Cancer (CIBERONC), ISCIII, Madrid, Spain.
  • Teigler-Schlegel A; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
  • Zur Stadt U; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.
  • Lentes J; CIBER de Cancer (CIBERONC), ISCIII, Madrid, Spain.
  • Göhring G; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
  • Kustanovich A; Department of Experimental Pathology and Cytology, Institute of Pathology, Giessen, Germany.
  • Aleinikova O; Center for Diagnostic, University Medical Center Hamburg Eppendorf, Hamburg, Germany.
  • Schäfer BW; Department of Human Genetics, Hannover Medical School, Hanover, Germany.
  • Kubetzko S; Department of Human Genetics, Hannover Medical School, Hanover, Germany.
  • Madsen HO; Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Republic of Belarus.
  • Gruhn B; Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Republic of Belarus.
  • Duarte X; Department of Oncology, University Children's Hospital Zurich, Zurich, Switzerland.
  • Gameiro P; Department of Oncology, University Children's Hospital Zurich, Zurich, Switzerland.
  • Lippert E; Department of Clinical Immunology, University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Bidet A; Department of Pediatrics, Jena University Hospital, Jena, Germany.
  • Cayuela JM; Department of Pediatrics, Portuguese Institute of Oncology of Lisbon, Lisbon, Portugal.
  • Clappier E; Hemato-Oncology Laboratory, UIPM, Portuguese Institute of Oncology of Lisbon, Lisbon, Portugal.
  • Alonso CN; Hématologie Biologique, CHU de Brest and INSERM U1078, Université de Bretagne Occidentale, Brest, France.
Leukemia ; 32(2): 273-284, 2018 02.
Article in En | MEDLINE | ID: mdl-28701730
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Histone-Lysine N-Methyltransferase / Myeloid-Lymphoid Leukemia Protein Limits: Adult / Child / Female / Humans / Infant / Male Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2018 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Histone-Lysine N-Methyltransferase / Myeloid-Lymphoid Leukemia Protein Limits: Adult / Child / Female / Humans / Infant / Male Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2018 Document type: Article Affiliation country: Country of publication: